See also
ˇ Show More
Comprehensive income is the change in equity (net assets) of a business enterprise during a period from transactions and other events and circumstances from non-owners sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.
You have visited 10 password protected pages for free. Others contain data covered by 
.
Sign Up Now to get full access to whole website and cut out all advertisements.
Novo Nordisk A/S, Consolidated Statement of Comprehensive Income
USD $ in millions, translated from DKK kr
| 12 months ended | Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | Dec 31, 2007 | |
|---|---|---|---|---|---|---|
 |
Net profit for the year | |
|
|
|
|
|
Realisation of previously deferred (gains) losses on cash flow hedges to Income statement | |
|
|
|
|
|
Deferred gains (losses) on cash flows hedges arising during the period | |
|
|
|
|
|
Exchange rate adjustment of investments in subsidiaries | |
|
|
|
|
|
Deferred gains (losses) on equity investments | |
|
|
|
|
|
Share of other comprehensive income of associated companies, net of tax | |
|
|
|
|
|
Other | |
|
|
|
|
|
Tax on other comprehensive income, income (expense) | |
|
|
|
|
|
Other comprehensive income for the year, net of tax | |
|
|
|
|
|
Comprehensive income for the year | |
|
|
|
|
| Item | Description | The company |
|---|---|---|
| Deferred gains (losses) on cash flows hedges arising during the period | Net of tax effect change in accumulated gains and losses from derivative instruments designated and qualifying as the effective portion of cash flow hedges, after taxes, that is attributable to the parent entity. A cash flow hedge is a hedge of the exposure to variability in the cash flows of a recognized asset or liability or a forecasted transaction that is attributable to a particular risk. The change includes an entity's share of an equity investee's increase (decrease) in deferred hedging gains or losses. | Novo Nordisk A/S's deferred gains (losses) on cash flows hedges arising during the period declined from 2009 to 2010 and from 2010 to 2011. |
| Exchange rate adjustment of investments in subsidiaries | Adjustment that results from the process of translating subsidiary financial statements and foreign equity investments into functional currency of the reporting entity, net of tax, attributable to the parent entity. | Novo Nordisk A/S's exchange rate adjustment of investments in subsidiaries declined from 2009 to 2010 and from 2010 to 2011. |
| Deferred gains (losses) on equity investments | Gross appreciation or the gross loss in value of the total unsold securities at the end of an accounting period, after tax, attributable to the parent entity. | Novo Nordisk A/S's deferred gains (losses) on equity investments declined from 2009 to 2010 but then increased from 2010 to 2011 exceeding 2009 level. |
| Comprehensive income for the year | The change in equity [net assets] of a business enterprise during a period from transactions and other events and circumstances from non-owner sources which are attributable to the reporting entity. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners, but excludes any and all transactions which are directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent. | Novo Nordisk A/S's comprehensive income for the year increased from 2009 to 2010 and from 2010 to 2011. |
May 23, 2012